Lv2
150 积分 2024-09-02 加入
Baxdrostat for the treatment of primary aldosteronism: current evidence
1个月前
已完结
A first-in-class JAK/ROCK inhibitor, rovadicitinib, for glucocorticoid-refractory or -dependent chronic GVHD
1个月前
已完结
High Rates of Chronic GVHD Flares after Ruxolitinib Taper or Discontinuation
3个月前
已关闭
Targeted dosing of anti‐thymocyte globulin in adult unmanipulated haploidentical peripheral blood stem cell transplantation: A single‐arm, phase 2 trial
7个月前
已完结
Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies
7个月前
已完结
Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin
8个月前
已完结
A First-in-Class JAK/ROCK Inhibitor, Rovadicitinib, for Glucocorticoid-Refractory or -Dependent Chronic GVHD
8个月前
已完结
Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin‐4‐IgG4‐Fc in healthy subjects: A phase 1, single‐centre, randomized, double‐blind, dose escalation study
1年前
已完结
皖公网安备34019202002308
